Dedicated to primary cells<br /><span>Product and service development</span>
Dedicated to primary cells
Product and service development

Dedicated to the development of primary cell products and services

Learn More
Dedicated to primary cells<br /><span>Product and service development</span>
Dedicated to primary cells
Product and service development

Dedicated to the development of primary cell products and services

Learn More
Dedicated to primary cells<br /><span>Product and service development</span>
Dedicated to primary cells
Product and service development

Dedicated to the development of primary cell products and services

Learn More
scroll down

About Us

Dedicated to primary cells
Product and Service Development

Wuxi Hycells Biotechnology Co., Ltd. is an innovative biotechnology company specializing in primary cells, related reagents, and technical services. With a long-standing commitment to the fields of cell and gene therapy (CGT) and large-molecule therapeutics, the team is dedicated to providing customers with end-to-end, one-stop solutions for primary cell products—covering research and development, manufacturing, sales, and technical support.

View more

Sample Service

Learn more +
Consult Now +

Technical Service Platform

Learn more +
Consult Now +

Product Center

Quality first, innovation oriented

View more
Cultivation Products

Cultivation Products

.

Culture products generally refer to various reagents, consumables and equipment used for in vitro culture, expansion and maintenance of cells, and are widely used in scientific research, drug development, vaccine production, cell therapy and other fields.

Obtain Solutions →
Testing Products

Testing Products

.

Hycells is committed to becoming a leading global one-stop supplier of primary cells, related reagents, and services.

Obtain Solutions →
Other Products And Instruments

Other Products And Instruments

.

Hycells is committed to becoming a leading global one-stop supplier of primary cells, related reagents, and services.

Obtain Solutions →

Cultivation Products

Cultivation Products

Testing Products

Testing Products

Other Products And Instruments

Other Products And Instruments

Our Advantages

Primary Cells, Pharmacological Efficacy Services, and Product Services
One-Stop Expert in Upstream Cell Solutions

View more

Quality

High-quality technical standards

Professional

Professional laboratory research team

Compliance

Clinical Sample Collection Compliance System

After-sales

A comprehensive after-sales service system

News Updates

Stay updated on He Yousheng’s latest news

Company News
Industry News
Laws and Regulations

818 Breakthrough Technology | Integrated Culture Protocol for γδ T Cells

2026-03-16

The implementation of the “818 Regulations” marks the official entry of China’s cell therapy industry into a new phase of standardized development, one that prioritizes clinical efficacy as the benchmark for value, upholds rigorous compliance across the entire value chain as an inviolable baseline, and harnesses differentiated technological innovation as the core driver of progress. The Regulations explicitly restrict low-level duplication and homogeneous competition, while giving priority to the translation of technology pathways that demonstrate clear clinical value and outstanding scientific innovation, thereby establishing clear compliance boundaries and a well-defined innovation orientation for the industry’s future development.

Conference Announcement | Hycells cordially invites you to join the 3rd Boao Lecity Stem Cell Summit

2026-03-09

From March 20 to 22, 2026, the Third Boao Lecity Stem Cell Conference, co-hosted by the China Anti-Aging Promotion Association and Hainan University, will be held in Boao Lecity, Hainan. With the theme “Cell Therapy Pioneering the Third Medical Revolution,” the conference will also make a major announcement of the latest batch of cell therapy procedures that are now permitted to be billed, thereby establishing an international high-end platform that brings together cutting-edge ideas, translates research into clinical practice, fosters industry collaboration, and jointly develops policies and standards.

A Tribute to the Woman Who Provides “Cell-Level” Protection in the Field of Life Sciences

2026-03-08

In the world of biopharmaceuticals, cells are the fundamental units of life; at Hycells Biotechnology, women are the driving force behind global progress. From relentless pursuit in the laboratory to compassionate care on the clinical front lines, women’s sensitivity, resilience, and wisdom—like the “primary cell” technology we have meticulously cultivated—harness the most primal and essential power to propel innovation and shape the future of our field.

Live Stream Preview | Integrated NK Cell Culture Protocol: A Comprehensive Analysis from Process Development to Application

2026-03-04

Hycells Biotechnology is a biotechnology innovation company specializing in research on primary immune cells and hepatocytes. We are committed to providing customers with comprehensive, one-stop solutions for immune cells and stem cells, leveraging scientific innovation to drive industry development and delivering expert services to empower clinical research.

3.0 High-Efficiency NK Serum-Free Culture Kit | Chapter 1: Cord Blood–Derived CBNK

2026-02-27

Hycells Biotechnology’s newly launched 3.0 High-Efficiency Serum-Free NK Cell Culture Kit (Catalog No.: NK888-2L), in collaboration with the CBMC Seed Bank, provides a comprehensive, integrated cell culture solution: from thawing and recovering CBMC seed stocks or directly and efficiently expanding fresh CBMCs, to ultimately obtaining NK cells with high purity and high viability. This integrated culture system supports flexible expansion based on cell status, with a scalable culture volume of up to 10 liters, delivering outstanding culture performance and exceptional cost-effectiveness, and earning widespread trust and recognition from customers.

New Product | Hycells Announces the Launch of High-Viability Primary Hepatocyte Cells!

2026-02-11

Within 4 hours after recovery, its cytochrome P450 enzyme activity is most similar to that in vivo, making it suitable for short-term metabolic studies.

Quickly access products and solutions

Currently, Heyousheng has established nearly 1,000 square meters of R&D laboratories and has officially obtained GB/T 19001-2016/ISO 9001:2015 quality management system certification. The company has also been recognized as a “Shanghai High-Tech Enterprise” and a “Shanghai Specialized, Sophisticated, Distinctive, and Innovative SME.” Heyousheng is committed to becoming a world-leading one-stop supplier of primary cells, associated reagents, and related services.

Contact us now
021-36696819